Tech Company Financing Transactions

Avidity Biosciences Funding Round

Avidity Biosciences secured a $16 million Series B investment round on 1/6/2017. Investors included Takeda Ventures, Brace Pharma and EcoR1 Capital Management.

Transaction Overview

Company Information

Company Status

Publicly-held

Industry

Biopharmaceutical

Mailing Address

10975 North Torrey Pines Rd. 150
La Jolla, CA 92037
USA

Phone

(858) 401-7900

Website

www.aviditybiosciences.com

Email Address

[email protected]

Overview

Avidity Biosciences LLC offers research, development, and manufacturing of drug candidates which include antibody-siRNA complexes.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chairman

Troy Wilson

        

Chief Executive Officer

Sarah Boyce

        

Chief Scientific Officer

Arthur Levin

        

Vice President

Andrew Geall

        

Vice President

John Wallen

        

VP - Bus. Development

Kent Hawryluk

        

VP - Finance

Vanessa Jacoby

        

Browse more venture capital transactions:

Prev: 1/6/2017: Orion Labs venture capital transaction
Next: 1/6/2017: ClearScholar venture capital transaction

Share this article

Where The Data Comes From

We do our best to record every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary